Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MNK1 is a serine/threonine protein kinase that interacts with and is activated by the mitogen-activated protein kinases ERK1 and p38. It plays a key role in cellular signaling pathways, particularly those involved in the response to growth factors, stress stimuli, and cytokines. It regulates mRNA translation by phosphorylating eIF4E, modulates cytokine production in T cells, and demonstrates a protective role against cardiac remodeling.
MNK1 inhibitors block eIF4E phosphorylation, thereby inhibiting cap-dependent translation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen‑activated protein kinase‑interacting serine/threonine-protein kinase 1 (MNK1).